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Abstract This study explores illness representations within Familial Amyloidotic Polyneuropathy Portuguese Associa-
tion newspaper . A content analysis was performed of the issue data using provisional coding related to the
conceptual framework of the study. All dimensions of illness representation in Leventhal’s Common Sense
Model of illness cognitions and behaviors are present in the data and reflect the experience of living with this
disease. Understanding how a person living with an hereditary, rare, neurodegenerative illness is important for
developing community nursing interventions. In conclusion, we suggest an integration of common sense
knowledge with other approaches for designing an intervention program centered on people living with an
hereditary neurodegenerative illness, such as familial amyloidotic polyneuropathy.
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INTRODUCTION
Familial amyloidotic polyneuropathy (FAP) is a rare, heredi-
tary, irreversible, and fatal neurodegenerative disease result-
ing from a genetic mutation (Ando et al., 2013). FAP mainly
affects the peripheral nervous system at a late age of onset,
between 25–35 years, and causes high dependency levels,
suffering, and premature death (Conceição, 2006). The
extracellular deposition along the peripheral nervous system
of insoluble amyloid protein fibers (transthyretin) and amor-
phous compounds is reflected by a sensory loss that starts in
the feet, accompanied in some cases by pain in the lower
limbs, in contrast to the loss of thermal sensitivity that arises
in others (Said, 2003). Diagnosis can be difficult, especially if
there is no previous family history. Although it endemically
originating on the northwest coast of Portugal, multiple
endemic foci have been discovered at a high prevalence in
different countries, such as Sweden and Japan (Sousa &
Saraiva, 2003; Ohmori et al., 2004; Zaros et al., 2008). Consid-
ered a rare disease, molecular testing has proved that it has
spread worldwide and outside the well-defined and identified
endemic foci (Fleming et al., 2009).The Portuguese mutation,
the most prevalent, is also accompanied by a more severe
symptoms, an earlier onset, and an anticipation phenomenon
of symptoms dependent on gender (Lemos et al., 2014).
Treatment options for patients with FAP are very limited and
focus on palliation of symptoms to halt disease progression
or to stabilize the tetramer (Suhr et al., 2000; Coelho et al.,
2013). Symptomatic treatment can improve the quality of life
of these patients, and is addressed primarily to peripheral
neuropathy (Ando et al., 2013).
Literature review
In daily life we construct beliefs and representations of the
world that surround us. Similarly, when someone experiences
a symptom, like a headache, or receives some health/illness
information, they seek meaning for this new information
(Weinman & Petrie, 1997). Disease perception, beliefs, and
representations influence coping responses and adaptation to
a new health situation (Petrie & Weinman, 2006). The
Common Sense Model of illness cognitions and behaviors
provides a framework to assist in understanding the experi-
ence of patients with any chronic illness (Baines &
Wittkowski, 2013). This model is organized in four stages: (i)
the moment an individual perceives a stimulus, symptom, or
result of a health test; (ii) identification, which corresponds to
the construction of the illness representation and emotional
responses based on the stimuli previously perceived; (iii)
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coping behaviors, which emerge from the previous stage and
direct themselves to the illness and emotional control
responses; and (iv) appraisal, which requires the evaluation of
coping outcomes (Leventhal et al., 1997). The illness repre-
sentation formation is an active process that involves emo-
tional and cognitive proceedings, recursive stages of appraisal
and representation,and a hierarchical process of concrete and
abstract thinking (Leventhal et al., 1997). For the construction
of illness representation, this model presents five components
or dimensions that relate to each other and contribute to the
building of a mental model: identity of the illness, causal
beliefs, timeline beliefs, cure or controllability beliefs, and
consequences of illness (Petrie & Weinman, 2006). Inherited
genetic diseases pose a challenge to illness representations,
because, as shown in some studies, people emphasize the
characteristics inherited from parents, but do not realize the
relationship with genes (Marteau & Senior, 1997). FAP is an
inherited neurodegenerative disease, in which the age of
onset of the disabling symptoms occurs in young adults. In
other neurodegenerative and disabling diseases, the role of
illness representation is well known, and mediates prognosis
and quality of life (Vaughan et al., 2003; Graves et al., 2009;
Ferreira et al., 2010). Media represent an important means to
disseminate information about diseases, treatments, and
available resources. However, not all images displayed by the
media are correct, often inducing erroneous and stigmal
beliefs in the community about people with certain diseases
and influencing the illness representation of the person living
with the disease (Collin & Hughes, 2011; Drazic &
Caltabiano, 2012; Holland, 2012; Rukavina et al., 2012). In the
case of FAP, as an hereditary disease with a strong psychoso-
cial impact, it is important to perform an analysis of the news
published by the association representing the interests of the
persons living with it. Is it important in order to understand
more about people’s lived experience with the disease in
order to deliver patient centered nursing interventions
Study aim
This study explores the illness representations expressed in
the newspapers published by the Familial Amyloidotic
Polyneuropathy Portuguese Association.
METHODS
The primary source of this qualitative study was data
collected from the newspapers published by the Familial
Amyloidotic Polyneuropathy Portuguese Association since
December 1980. All issues published from 1980–2014 were
analyzed.A total of 44 issues were obtained from the Familial
Amyloidotic Polyneuropathy Portuguese Association and
from municipal libraries. Content analysis was performed
using Milles et al.’s (2014) qualitative data analysis method.
The authors were guided by the Common Sense Model, a
conceptual framework (Leventhal et al., 1997). Content
analysis was performed using provisional coding related to
the study’s conceptual framework (Saldaña, 2009). All arti-
cles published in the journal were screened, and news related
to the illness or the experience of living with FAP were
included in the study. News of funding events, association
activities, and financial reports were excluded because they
were not directly connected to the object of the study. The
representativeness of this study was achieved because we
used all of the issues published to date. Because of the small
volume of data and categories, we chose to perform a manual
content analysis without recourse to a computer program for
data processing. Different colors were assigned to the catego-
ries and a deep reading of all articles was performed. A
database with the different categories was created a priori in
which relevant registration units were transcribed and coded.
RESULTS
The authors analyzed the 44 issues published; as this news-
paper was not regularly published until 1999, there were
some years in which only an annual issue was published and
there were also years in which no issue was published. Since
1996, only one issue has been published annually, usually in
December. Five categories emerged that were then included
into a core category – illness representation.
Identity
The identity domain includes disease diagnosis or the label
attached to the disease and associated symptoms. The iden-
tity of the illness is related to the patients’ beliefs about
possible or actual labels for the condition and the symptoms
experienced. The most common diagnostic designation was
Paramiloidose, a popular term designating the disease. In
more recent news, we note the use of the term “familial
amyloidotic polyneuropathy” or “FAP.” There are two ways
to identify an individual diagnosed with FAP: the first is by
using the term “Paramiloidótico,” identifying the person with
the illness; the second is to designate them as an FAP patient
or a person with FAP. We found a relationship between the
signs and symptoms of the disease, which are used as desig-
nators, such as doença dos pezinhos, an idiomatic expression
that cannot be translated into English but relates to the most
visible symptom, that is, impaired walking.
Cause
Beliefs about the causes of a disease are important in building
a representation of illness. After reading the news, we have
identified two causes for FAP: biochemical and genetic/
hereditary causes. Biochemically, the cause is attributed to a
disorder in the accumulation of amyloid substance.The exem-
plar used within the journal to express biochemical causes are:
The importance of the foreign substance, amyloid, that
accumulates in nerves and other organs of patients.J.2,3,4
It has been shown that the protein that becomes abnor-
mal substance gives the name of the disease: amyloid J.18
. . . in FAP a protein that normally circulates in the blood
has a conformation which leads to abnormalities depos-
it[ed] in various locations in the body including periph-
eral nerve, in the form of a substance called amyloid J.20
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This causal belief is present in the first combination of
issues, as well as in the most recent issues, and is particularly
associated with the appearance of tafamidis. The assignment
of the disease to hereditary/genetic causes has family, emo-
tional and social implications, as can be verified by the
excerpts presented:
Patients are carriers of a genetic abnormality that they
transmit to a part of their children this ability to manu-
facture the abnormal protein J.2,3,4
I know it is a hereditary disease that is transmitted from
parents to children J.7,8,9,10
Where (. . .) is discovered that I had “inherited” my
father this strange disease J.11
It is known today the responsible gene, its chromosomal
location, the mutation suffered and mutant protein that
results from it. J.18
Some expressions reinforce or affirm this genetic cause,
such as:
Genetic defect J.23
The origin is genetic J.24
Timeline beliefs
From our data, we can see that perceptions of the natural
course of the disease are related to the age of the onset of
symptoms and the progression of severity of symptoms to
disability and death:
One of the earliest symptoms in Paramiloidose is the
digestive disorders, often accompanied by poor appetite
and marked weight loss J.1
Early in the disease Paramiloidóticos begin to have
digestive complaints – Constipation, bouts of diarrhea,
prolonged and difficult digestion, morning vomiting J.13
The first symptoms appeared in the form of bites, lack of
muscle strength, lack of sensitivity to hot and cold and
also pain, mainly in the lower limbs J.43
Through these examples, we understand the natural course of
the disease and the expected severity in the progression of
symptoms. Representations submitted in the newspapers
show a serious, progressive illness, which, until very recently,
led to death involving great suffering:
Terrible disease (. . .) that is chronic, progressive and
disabling J.11
The outcome is always fatal (. . .) No cure J.23
I have to live with (. . .) it is chronic J.28
. . . A disease that has no cure and inevitably (. . .) led
patients to death prematurely J.41
Cure or controllability beliefs
Beliefs about disease control emerged from the news analy-
sis, related with timeline beliefs of chronicity. One
transmitted belief is the possibility to control or eradicate the
disease in progeny, either by refusing to have children, the
use of prenatal diagnosis, or preimplantation diagnosis.
The achievement of presymptomatic diagnosis in the off-
spring of patients with FAP was discussed in the first issue.
More recent articles introduced the notion of self-care man-
agement and its influence in health decisions:
. . . The only way to wipe out the disease would be that
individuals at risk (. . .) decided, knowing its mode of
transmission not [to] have children J.7,8,9,10
Early diagnosis of (. . .) Paramiloidose is the most effec-
tive means of disease containment (. . .) [and] will allow
accurate genetic counseling J.11
Do some physical activity. J.43
Beliefs of the role of health professionals in the control or
cure of this disease mainly focus on the need for specific
training to care for patients, the need for proximity care
services, and research of new treatments. For some patients,
the lack of effective treatment leads to a sense of hopeless-
ness and a loss of confidence in healthcare professionals. Poor
information and the detachment of some health profession-
als toward this disease, lead to a loss of confidence in disease
control:
. . . An evil that no one deigns resolve after so many
years it exists in our country (. . .) and others (. . .) will
suffer, waiting for someone of medical profession should
say that this is in the way to being cured; it has now gone
many years of fruitless studies. J.7,8,9,10
Liver transplantation (. . .) changed the situation until
then incurable disease and has changed the way patients
live and regard disease. J.37
Since I started taking the medication, the changes have
been slow but positive. J.41
Consequences
Representations of the consequences of the disease on
patients allow us to evaluate its impact in the short and long
term at physical, emotional, social, and economic levels
(Baines & Wittkowski, 2013). This dimension emphasizes
individual subjectivity in perceptions of disease severity. Per-
ception of the physical consequences relates to the impact
that the symptoms have on everyday activities. These repre-
sentations of FAP are conceptualized by personal experience
of the disease, but also by past experience of parents or other
relatives:
Disease (. . .) which causes muscle weakness of the limbs
(. . .) Begin to lose strength in the feet, legs and hands
(. . .) Often (. . .) the patient is unable to move. J.18
Patient is (. . .) often in pain, unable to walk normally.
J.24
When I was seven I realized that my father was not like
other parents, was very thin, walked with difficulty, what
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little he ate did him harm, he had constant diarrhea, was
incontinent, and he did not distinguish heat and cold in
his hands and feet J.36
Perception of emotional consequences relates to beliefs con-
nected with the progressive evolution of symptoms, the suf-
fering associated with the disease, and social isolation that
the disease leads to. Previous experiences with parents’
illness construct a perception of the disease, associated with
suffering and hopelessness:
I went through severe depression, having come to think
the worst (. . .) What else has cost me so far is not exactly
physical suffering itself, but rather accepting the disabili-
ties that this disease has brought me. J.11
We feel that in the skin, we all live fast, because we say
from past experience that the time of the great forces
will be short and the failure is coming. J.24
When I look in the mirror it happens to me to see my
father’s face (. . .) I realize there’s a bit of his suffering
now in my body. J.36
Perceived economic and social consequences go hand in
hand. The economic consequences discussed initially focused
mainly on the cost and access to medicine in relation to those
with low or non-existent incomes, and frequently regarding
large families with small children. In the most recent issues,
this social and economic aspect is less frequently mentioned;
instead, the difficulty of travel to hospital to acquire liver
transplant medication or tafamidis is often discussed:
The ongoing support of the disease requires medica-
tions, mostly at prohibitive prices, despite the contribu-
tion J.2,3,4
Force (. . .) the individual to leave his employment too
early, causing a reduction in household income J.23
Others have (. . .) increasingly difficult access to consul-
tations J.42
The news discuss perceived social consequences, referring to
social rights, poor housing conditions, and the consequences
of diagnosis to decisions regarding choices of employment,
marriage, and children:
There are patients living in poor conditions, as all the
houses are not architecturally prepared for its shortcom-
ings. J.11
If one has this knowledge it will be more prepared to
face your future and may in time make certain choices in
your life according to the characteristics of the disease
J.11
The diagnosis may influence their career choices (. . .)
and can still influence family planning J.24
DISCUSSION
Through our analysis of the FAP Portuguese Association
journal articles and use of the Common Sense Model as a
conceptual framework, we have identified five dimensions:
identity, causal beliefs, timeline beliefs, cure or controllability
beliefs, and the consequences of the illness (Leventhal et al.,
1997). The FAP patients’ perceived self-care deficit and
beliefs about treatments are only superficially discussed in
the articles. Identification of this disease is mostly performed
by diagnostic label and the carrier of the disease or patient is
identified mostly with an adjective derived from it. The label
that designates the person that lives with a genetic condition
is important because, in this case, the disease is a part of the
biological identity of the person (Mendes, 2007).This is more
significant, because the FAP is an inherited genetic disorder,
whereby from the moment that the patient carries the genetic
diagnosis it is registered in his identity (Marteau & Senior,
1997; Mendes, 2007). Identification of the symptoms of the
disease can lead the patient to devalue side effects of the
treatment or non-adherence behaviors. The popular
use of the expression doença dos pezinhos used to designate
this disease is evidence of this identification of a disease by
one visible symptom. (Llewellyn et al., 2007; Baines &
Wittkowski, 2013). Beliefs regarding the causes for the
appearance of a disease allow us to know the perception of
the factors or conditions that led to the emergence of a
disease (Llewellyn et al., 2007). It is important to know if the
individual’s attitude or behavior influences the curse of the
illness, as well as their emotional responses, including
the allocation of responsibility for the disease (Byrne et al.,
2005). Biochemical mechanisms or genetic/hereditary muta-
tions are attributed as the causes of this disease.The question
of heredity leads us to the social and emotional consequences
of the disease, as well as the representations of individual
disease control (Marteau & Senior, 1997). Biochemical
causes lead us to perceive physical consequences and a
natural course of the disease, while representations of disease
control signify the importance of health professionals and
treatment. Causal belief influences decisionmaking of indi-
vidual and family aspects of future life, the choice of profes-
sional carrier, paternity, marriage, and treatment decisions in
FAP carriers (Martinho et al., 2012). Timeline beliefs, related
to perceptions of the duration of the disease, particularly in
the case of chronic illness, are important because of the close
relationship with treatment adherence (Llewellyn et al.,
2007). The prognosis and natural course of FAP leaves no
room for hope. We know that patients who undergo a liver
transplant experience illness progression after 10 years, and
we know that the efficacy of the transthyretin tetramer sta-
bilization drug is 60% (Obayashi & Ando, 2012; Coelho et al.,
2013; Oshima et al., 2014). If the timeline were prolonged, a
person with FAP could hope to live longer with a better
quality of life than their parent, even when the anticipation
phenomenon is present (Lemos et al., 2014).These beliefs are
related to the ideation of by cure or control dependent on
personal resources, treatments, or by the action of health
professionals on the illness (Ferreira et al., 2010). Until 1990,
there was no hope of control over disease progression;
support and palliative treatments were the only available
options. Liver transplant was the first effective treatment to
slow down disease progression; however, many patients died
during the procedure, and the later a patient underwent a
transplant, the lower quality of life they could expect because
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of remaining symptoms (Suhr et al., 2005). There is currently
no curable treatment; the disease can be controlled by treat-
ment for a period of time, but the carrier will still transmit the
mutation to the next generation. There are three sources of
information to build a representation of the disease accord-
ing to the Common Sense Model of Illness, namely, physical
experience of the illness, information provided by an agent
(healthcare professional, media, family or friends, patient
associations), and information based on past experience of
the disease (Hagger & Orbell, 2003; Baines & Wittkowski,
2013). Studies conducted within this conceptual framework
of patients with FAP determined that these are also the
funding sources for obtaining information about the disease
(Jonsèn et al., 1998; 2000; Martinho & Martins, 2011).
Limitations
This study was conducted with the limitation of having a
unique source, the newspaper published by the Familial
Amyloidotic Polyneuropathy Portuguese Association. Deter-
mining the existence of other similar associations and their
focus on the disease, would be beneficial in order to study
local illness representation. The perception of a serious, pro-
gressive, and fatal disease that affects an individual at a young
and active age has consequences that influence life choices of
patients. However, articles alone cannot demonstrate the
influence of family history on previous beliefs and percep-
tions of the disease and its impact on self-care of the patient
(Leventhal et al., 1998). It is also difficult to understand the
relationship between disease stage and illness representation
of the patient and their family (Arran et al., 2013).
CONCLUSION
The illness representation of a disease is a very important
part of a system of beliefs, affecting a healthy transition. This
representation is built not only on an individual’s previous
illness experience, but also by the images the media conveys
of that specific disease, which constitutes a version of the
social representation of that illness. In order to promote
healthier transitions and to deconstruct incorrect beliefs, it is
important for nurses to be aware of the social representation
of an illness. The choice of the Common Sense Model in this
study was helpful in achieving the proposed goal. It was
possible to identify all the dimensions proposed by the
model, and to establish tenuous links between these dimen-
sions. Although this is a rare disease worldwide, endemic foci
affects a significant number of families. New treatment pos-
sibilities launch important data that needs to be studied in the
light of this model, namely the introduction and cost of
orphan drugs used, as well as any changes that result from the
stabilization of disease progression that can, in turn, bring a
new representation of the disease.
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